S C Schimpff, W H Greene, V M Young, P H Wiernik. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » AgranulocytosisCarbenicillin/therapeutic useCephalothin/therapeutic useEnterococcus faecalis/isolation & purificationEscherichia coli/isolation & purificationGentamicins/therapeutic useHumansKlebsiella/isolation & purificationLeukemia/complicationsLymphoma/complicationsPolymyxins/therapeutic usePseudomonas Infections/complicationsPseudomonas Infections/drug therapyPseudomonas Infections/epidemiologyPseudomonas Infections/prevention & controlPseudomonas aeruginosa/isolation & purificationSepsis/complicationsSepsis/drug therapySepsis/epidemiologySepsis/prevention & controlStaphylococcus/isolation & purification
Substances: See more » GentamicinsPolymyxinsCarbenicillinCephalothin
Year: 1973 PMID: 4372051 DOI: 10.1016/0014-2964(73)90110-2
Source DB: PubMed Journal: Eur J Cancer ISSN: 0014-2964 Impact factor: 9.162